Clinical Trial Update: Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of omecamtiv mecarbil on exercise capacity in patients with heart failure with reduced ejection fraction has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• omecamtiv mecarbil (omecamtiv mecarbil)

Snippet

Sponsor: Cytokinetics | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 3 | Status: COMPLETED | Results posted: 2023-03-07